BridgeMD
New treatment option for Atheromatous
Official title Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs?
ClinicalTrials.gov ID: NCT06226844
What this study is testing
- What it's testing
- Vascular rehabilitation for arteriopathy of the lower limbs remains little known in France, despite its good results. There are very few rehabilitation centres, and they are overcrowded and expensive.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with stage II arterial obliteration of the lower limbs (Leriche and Fontaine classification) with exertional claudication
- Systolic Pressure Index at the toe \ 30 mmHg
- Steno-occlusive lesions on arterial Doppler ultrasound examination of the lower limbs
- Patient on an optimised vasculoprotective medical treatment (statin, antiplatelet agent, ACE inhibitor/ARB II)
- Patient who is a beneficiary or entitled beneficiary of a health insurance scheme
You likely can't join if
- Patients using walking aids (cane, wheelchair)
- Amputation
- Patient with a walking perimeter \< 150 m
- Hearing or visual impairment
- Chronic ischaemia
- Trophic disorders
See the full eligibility criteria
- Patient with stage II arterial obliteration of the lower limbs (Leriche and Fontaine classification) with exertional claudication
- Systolic Pressure Index at the toe \ 30 mmHg
- Steno-occlusive lesions on arterial Doppler ultrasound examination of the lower limbs
- Patient on an optimised vasculoprotective medical treatment (statin, antiplatelet agent, ACE inhibitor/ARB II)
- Patient who is a beneficiary or entitled beneficiary of a health insurance scheme
- Patient able to understand, write and read French
- Patient who has given free and informed consent
- Patients using walking aids (cane, wheelchair)
- Amputation
- Patient with a walking perimeter \< 150 m
- Hearing or visual impairment
- Chronic ischaemia
- Trophic disorders
- Orthopaedic or vascular MI surgery planned within 3 months
- Major cardiovascular co-morbidities (MI \< 3 months or unstable angina)
- Pregnant, breast-feeding or parturient women
- Patients under court protection, guardianship or curatorship.
The study team makes the final eligibility decision.
Where it's taking place
- Nîmes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nîmes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.